(Q28287283)

English

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV (English)

0 references

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

2

object named as

Galia Askarieh

0 references

object named as

Nina Weis

3

0 references

object named as

Martin Lagging

6

0 references

Kristoffer Hellstrand

object named as

Kristoffer Hellstrand

4

0 references

author name string

Karolin Falconer

1

0 references

Galia Askarieh

2

0 references

Annette Alaeus

5

0 references

language of work or name

0 references

publication date

December 2010

0 references

Infectious Diseases

0 references

42

0 references

11-12

0 references

896-901

0 references

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3109/00365548.2010.498019

21 April 2017

High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin trea

1 reference

https://api.crossref.org/works/10.3109/00365548.2010.498019

21 April 2017

Epidemiology of viral hepatitis and HIV co-infection

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

HCV/HIV co-infection at a large HIV outpatient clinic in Sweden: feasibility and results of hepatitis C treatment

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

First phase hepatitis c viral kinetics in previous nonresponders patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2010.498019

21 January 2018

Identifiers

10.3109/00365548.2010.498019

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28287283&oldid=1953863128"